Here's the roundup of the latest coronavirus-related news.
The coronavirus disease 2019 (COVID-19) vaccination effort is well underway in the US, with over 35.2 million administered doses and 2.1% of the population fully vaccinated against the virus as of press time. This week, President Biden announced that the government will be shipping vaccines directly to retail pharmacies, and Johnson & Johnson prepares to submit an emergency use authorization (EUA) to the FDA for its 1-dose vaccine candidate.
Here’s a roundup of the latest coronavirus-related news:
In the absence of proven treatments for COVID-19, a variety of pharmaceutical agents have been explored for their potential benefit. Alongside these pharmaceutical agents, a number of dietary supplements, such as vitamin C, zinc, and magnesium have been used as well. One particular vitamin that has caught the attention of both health care professionals and consumers is vitamin D.
The Biden-Harris administration announced on Tuesday that, starting next week, pharmacies across the US will begin directly receiving federal deliveries of COVID-19 vaccines.
The FDA authorization of the Pfizer/BioNTech and the Moderna vaccines for emergency use against COVID-19 has propelled the United States forward in its battle against the virus. Both vaccines are promoted as being up to 95% effective after the second dose is administered, but how many recipients will complete the series to achieve maximum protection?
Johnson & Johnson’s COVID-19 vaccine candidate is 66% effective in preventing moderate-to-severe COVID-19 and met all primary and secondary end points of its phase 3 ENSEMBLE clinical trial, according to a news release.
Patients with HIV experience worse COVID-19-related outcomes compared to those without the diagnosis, according to new findings.